Stocksigma LogoStocksigma Logo

Fischer Medical Ventures Appoints David Yeow as Independent Director and Reconstitutes Audit Committee

Fischer Medical Ventures appointed Mr. David Yeow as an Additional Independent Director for a five-year term, effective 3rd Sep'26

Fischer Medical Ventures Appoints David Yeow as Independent Director and Reconstitutes Audit Committee

Fischer Medical Ventures Ltd 路 Outcome 路 03 Sept 2026, 8:14 pm

Fischer Medical Ventures Appoints David Yeow as Independent Director and Reconstitutes Audit Committee Fischer Medical Ventures appointed Mr. David Yeow as an Additional Independent Director for a five-year term, effective 3rd Sep'26. Yeow, Principal at medical device VC Hunniwell Lake Ventures, brings over 30 years of technology commercialization expertise. Consequently, the Board reconstituted its Audit Committee, adding Yeow as a member alongside six others. Additionally, the company scheduled its 33rd AGM for 29th Sep'26 via video conferencing. To facilitate the AGM, the company's share transfer books will remain closed from 23rd Sep'26 to 29th Sep'26.

Original exchange filing (PDF)

More announcements from Fischer Medical Ventures Ltd

All Fischer Medical Ventures Ltd announcements